A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis
Small · 2024-06 · 20 (25)
DOI: 10.1002/smll.202307261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.01.2024. Verfasst von Qingting Zuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key laboratory of Drug Targeting and Drug Delivery System (Ministry of Education), West China School of Pharmacy, Sichuan University, No. 17, Block 3…. Hauptthemen laut MEDLINE: Photochemotherapy, Mitochondria, Arthritis, Rheumatoid, Liposomes. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Regional Innovation and Development Joint Fund, Science & Technology Department of Sichuan Province.
Abstract (Originalsprache)
Conventional photodynamic therapy (PDT) of rheumatoid arthritis (RA) faces a dilemma: low‐power is insufficient to kill pro‐inflammatory cells while high‐power exacerbates inflammation. Herein, mitochondrial targeting is introduced in PDT of RA to implement a “less‐is‐more” strategy, where higher apoptosis in pro‐inflammatory cells are achieved with lower laser power. In arthritic rats, chlorine 6‐loaded and mitochondria‐targeting liposomes (Ce6@M‐Lip) passively accumulated in inflamed joints, entered pro‐inflammatory macrophages, and actively localized to mitochondria, leading to enhanced mitochondrial dysfunction under laser irradiation. By effectively disrupting mitochondria, pro‐inflammatory macrophages are more susceptible to PDT, resulting in increased apoptosis initiation. Additionally, it identifies that high‐power irradiation caused cell rupture and release of endogenous danger signals that recruited and activated additional macrophages. In contrast, under low‐power irradiation, mitochondria‐targeting Ce6@M‐Lip not only prevented inflammation but also reduced pro‐inflammatory macrophage infiltration and pro‐inflammatory cytokine secretion. Overall, targeting mitochondria reconciled therapeutic efficacy and inflammation, thus enabling efficacious yet inflammation‐sparing PDT for RA. This highlights the promise of mitochondrial targeting to resolve the dilemma between anti‐inflammatory efficacy and inflammatory exacerbation in PDT by implementing a “less‐is‐more” strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key laboratory of Drug Targeting and Drug Delivery System (Ministry of Education), West China School of Pharmacy, Sichuan University, No. 17, Block 3, South Renmin Road, Chengdu, 610041, P.R. China.
ORCID-Profile: Yuan Huang
Förderung
- National Key Research and Development Program of China
- Regional Innovation and Development Joint Fund
- Science & Technology Department of Sichuan Province
- National Basic Research Program of China
Zitieren
APA
Zuo, Q., Lyu, J., Shen, X., Wang, F., Xing, L., Zhou, M., Zhou, Z., Li, L., & Huang, Y. (2024). A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis. Small, 20(25). https://doi.org/10.1002/smll.202307261
Vancouver
Zuo Q, Lyu J, Shen X, Wang F, Xing L, Zhou M, et al. A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis. Small. 2024;20(25). doi:10.1002/smll.202307261
BibTeX
@article{Zuo2024,
author = {Zuo, Qingting and Lyu, Jiayan and Shen, Xinran and Wang, Fengju and Xing, Liyun and Zhou, Minglu and Zhou, Zhou and Li, Lian and Huang, Yuan},
title = {A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis},
journal = {Small},
year = {2024},
volume = {20},
number = {25},
doi = {10.1002/smll.202307261}
}
EUVIMED